
Addis Ababa (December 23, 2025): Ethiopia and the United States have entered a new five-year health partnership valued at $1.6 billion, running from 2026 to 2030, officials from the two governments confirmed.
The cooperation framework prioritizes major infectious diseases—including HIV/Aids, tuberculosis, and malaria—while also expanding support for maternal and child healthcare and national capacity to detect and respond to public health emergencies.
A core part of the deal centers on strengthening Ethiopia’s health sector through training and expanding the medical workforce, increasing domestic health financing, and boosting local pharmaceutical manufacturing and supply chains.
The United States has committed $1.16 billion in direct financial support, while Ethiopia will cover the remaining share through a domestic health funding strategy designed to grow local investment in the sector.
The agreement was signed in the capital, Addis Ababa, by US Ambassador Ervin Massinga, Ethiopia’s Finance Minister Ahmed Shide, and Health Minister Mekdes Daba.
The new framework extends long-standing health cooperation between the two countries, which for more than 20 years has helped advance primary healthcare and community-led medical services across Ethiopia.
